More Medical News
Banzel Approved for Lennox-Gastaut Syndrome
11/21/2008

HealthDay - FRIDAY, Nov. 21 (HealthDay News) -- Banzel (rufinamide) has been
approved by the U.S. Food and Drug government to treat seizures
associated with Lennox-Gastaut syndrome, a severe form of epilepsy.

More: - Brought to my attention by

Share |
(Posted in Medical School)
Share and enjoy
  • Digg
  • del.icio.us
  • DZone
  • Netvouz
  • NewsVine
  • Reddit
  • Slashdot
  • StumbleUpon
  • Technorati
  • YahooMyWeb
Post Comment

Notify me of followup comments via e-mail.

Entry 1 of 14176
Last Page | Next Page